Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double-blind placebo-controlled study
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The aim of this study was to evaluate the therapeutic efficacy of intravenous immunoglobulin (IVIG) in the prevention of recurrent spontaneous abortion (RSA). In a double-blind, randomized, placebo-controlled study, 41 women with a history of unexplained recurrent spontaneous abortion were treated with IVIG or saline infusions during pregnancy. The birth of a child was considered a successful outcome. The overall success rate was 77% in the IVIG group compared with 79% in the placebo group. For women with primary RSA the success rates were 82 (IVIG) and 89% (placebo), and for women with secondary RSA the rates were 73 (IVIG) and 70% (placebo). We found no statistically significant difference in treatment results between IVIG and placebo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Future pregnancy outcome in unexplained recurrent first trimester miscarriage
Clifford, K., Rai, R., & Regan, L. (1997) · Human Reproduction · doi:10.1093/humrep/12.2.387 · Cited by 328
Cited by
Epidemiology and the medical causes of miscarriage
Regan, L., & Rai, R. (2000) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1053/beog.2000.0123 · Cited by 512
Recurrent pregnancy loss: current perspectives
El Hachem, H., Crepaux, V., May-Panloup, P., Descamps, P., Legendre, G., & Bouet, P.-E. (2017) · International Journal of Women's Health · doi:10.2147/ijwh.s100817 · Cited by 462
Recurrent miscarriage: aetiology, management and prognosis
Li, T. C. (2002) · Human Reproduction Update · doi:10.1093/humupd/8.5.463 · Cited by 435
Immunotherapy for recurrent miscarriage
Wong, L. F., Porter, T. F., & Scott, J. R. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000112.pub3 · Cited by 348
Evidence-based investigations and treatments of recurrent pregnancy loss
Christiansen, O. B., Nybo Andersen, A.-M., Bosch, E., Daya, S., Delves, P. J., Hviid, T. V., Kutteh, W. H., Laird, S. M., Li, T.-C., & van der Ven, K. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.12.018 · Cited by 302
Immunological Risk Factors in Recurrent Pregnancy Loss: Guidelines Versus Current State of the Art
Vomstein, K., Feil, K., Strobel, L., Aulitzky, A., Hofer-Tollinger, S., Kuon, R.-J., & Toth, B. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040869 · Cited by 113
Care prior to and during subsequent pregnancies following stillbirth for improving outcomes
Wojcieszek, A. M., Shepherd, E., Middleton, P., Lassi, Z. S., Wilson, T., Murphy, M. M., Heazell, A. E., Ellwood, D. A., Silver, R. M., & Flenady, V. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012203.pub2 · Cited by 55
Musters, A. M., Repping, S., Korevaar, J. C., Mastenbroek, S., Limpens, J., van der Veen, F., & Goddijn, M. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.12.022 · Cited by 41
“1 [12–23, 26–63]) (192 from electronic searchers, 3 from abstract books searched manually, 1 from reference lists of relevant publications).”
Background
Metadata
- Authors
- Jablonowska, B.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-03-01
- Volume
- 14
- Issue
- 3
- Pages
- 838-841
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W1993188608
- Cited by
- 107
- References
- 1
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.